Stakeholder Dialogue Session FY2013
Astellas held the following stakeholder dialogue with the aim of ascertaining expert opinions on selection of CSR core issues and medium-to long-term CSR activities that should be implemented.
Theme: CSR Activities Expected of Astellas
- Toshihiko Goto (Chairman, Environmental Auditing Research Group; Chief Executive Officer, Sustainability Forum Japan) (Top left)
- Kaori Kuroda (Executive Director, CSO Network Japan) (Top right)
- Naoki Aikawa, M.D., Ph.D. (Professor Emeritus, Keio University; Special Advisor, Social Welfare Organization Tokyo Saiseikai Central Hospital) (Bottom left)
- Moderator: Ayako Sonoda (President, Cre-en Inc.) (Bottom right)
Main Comments from External Stakeholders:
Considering Astellas' operations are worldwide and overseas sales ratio and non-Japanese shareholder ratio are high, CSR must be promoted from a global perspective.
For its CSR activities as a whole, Astellas is required to formulate and announce the Company' s approaches to various demands from society and to "soft law" * which embodies those demands in a more tangible form.
With the need to extend CSR across the entire value chain, from upstream to downstream, Astellas' scope of responsibility has expanded to include suppliers and business partners.
Engagement and collaboration with stakeholders have recently become increasingly crucial to monitoring social demands and issues and addressing them effectively.
Initiatives that utilize the strengths of pharmaceutical companies, especially those in specific to Astellas, should be bolstered. This is particularly important in addressing unmet medical needs. Astellas should understand the trends surrounding the International Development Goals beyond 2015 (Post-2015 Development Goals), which will be announced going forward.
It is crucial to strategically implement social contribution activities based on clearly defined goals.
For details, please see the Stakeholder Dialogue (Full Version).
Hosting the Stakeholder Dialogue
Kenji Yasukawa, Ph.D.
Former Senior Vice President and Chair of the CSR Committee, Astellas Pharma Inc.
In light of the changing environment we face, Astellas Group is currently evaluating various social demands from the standpoints of "the significance of the social issue" and "the relevance to Astellas' businesses," with the view to identifying materiality to CSR-based management. We are also considering disclosing the relevant details. With regard to analyzing the significance of social issues, in particular, we intend to carry out our evaluation by obtaining relevant stakeholders' expectations, in addition to gathering opinions within the Company.
Looking ahead, we will continue to do our utmost to put the advice we have obtained from external stakeholders to good use in CSR-based management at Astellas.